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Abstract
Purpose: In this study the effect of PLGA polymeric nanoparticles as a 5-fluorouracil (5-FU)
carrier with and without iron oxide core and hyperthermia were investigated on the level of
DNA damage in a spheroid culture model of HT-29 colon cancer cell lines by alkaline comet
assay.
Materials and methods: First, HT-29 colon cancer cells were cultured in vitro as spheroids with a
mean diameter of 100 mm. The spheroids were then treated with different concentrations of
5-FU or nanoparticles as 5-FU carriers with and without an iron oxide core for one volume-
doubling time of the spheroids (71 h) and hyperthermia at 43 C for 1 h. Finally, the effect of
treatment on viability and level of DNA damage was examined using trypan blue dye exclusion
assay and alkaline comet assay, respectively.
Results: Results showed that hyperthermia in combination with 5-FU or nanoparticles as 5-FU
carriers significantly induced the most DNA damage as compared with the control group. The
extent of DNA damage following treatment with 5-FU-loaded nanoparticles combined with
hyperthermia was significantly more than for 5-FU combined with hyperthermia. In comparison
to the effect of 5-FU-loaded nanoparticles with the iron oxide core and 5-FU-loaded
nanoparticle without the iron oxide core, the nanoparticles with the iron oxide core combined
with hyperthermia induced more DNA damage than the nanoparticles without the iron oxide
core.
Conclusions: According to this study, hyperthermia is a harmful agent and nanoparticles are
effective delivery vehicles for drugs into colon cancer cells. The iron oxide filled nanoparticles
increased the effect of the hyperthermia. All these factors have a significant role in the
treatment of colorectal cancer cells.
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Introduction
Colon cancer is the third most prevalent cancer and the fourth
most common cause of death in both men and women
worldwide. Several risk factors, including genetics, age,
personal history of adenomatous polyps, nutritional practices
and smoking are associated with this cancer [1]. Some of the
most common treatment methods include surgery, chemo-
therapy, radiotherapy and, in some countries, hyperthermia
[2]. Hyperthermia alone or in combination with other
modalities such as chemotherapy and radiotherapy is a well-
established method for treating cancer [3]. The cell-killing
potential of some but not all chemotherapeutic agents is
substantially enhanced by temperature elevation of even a few
degrees. Maeta et al. [4] showed temperature-mediated
elevation in the intracellular levels of 5-fluorouracil (5-FU)
in Ehrlich and sarcoma-180 tumour cells incubated with
5-FU. They observed that levels of 5-fluorouridine (FUR)
and 5-fluoro-20-deoxyuridine (FdUR), the active metabolites
of 5-FU, significantly increased in cells treated with 5-FU and
hyperthermia [4].
5-FU, a pyrimidine analogue, is used alone or in combin-
ation with other modalities to treat solid tumours such as
tumours of the gastrointestinal tract, pancreas, ovaries, liver,
brain and breasts. 5-FU is an S-phase-active agent that is not
active in other phases of the cell cycle. The resulting position
of cells in the cell cycle plays an important role in response to
drug therapy [5]. Because of its structure, 5-FU interferes with
nucleoside metabolism, converting to 5-fluorouridine triphos-
phate and 5-fluorodeoxyuridine monophosphate in the cell and
incorporating into RNA and DNA. This condition leads to
further genetic damage, particularly single- and double-strand
breaks in DNA, and, consequently, cell death [6,7].
However, 5-FU is associated with some disadvantages [6].
First, 5-FU is a hydrophilic drug and cannot pass through the
cell membrane. Second, it decomposes within the body and
results in severe side effects. Third, it undergoes rapid
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degradation and is required at high doses. Nanoparticles
can be used to overcome these limitations. However, the
nanoparticles used must be biocompatible and biodegradable.
Poly lactic-co-glycolic acid (PLGA) is just such polymer that
has no toxic effects and is capable of controlling the drug
release from nanoparticles [8,9]. PLGA is degraded by
hydrolysis into acid monomers and excreted from the body
by the Krebs cycle [10]. Because of their small size and
electromagnetic properties, nanoparticles can be useful [11].
Research suggests that chemotherapy in combination with
hyperthermia is more effective than chemotherapy alone [12].
Hyperthermia occurs when the body temperature increases to
more than 41 C because of external factors. In this method,
which is non-ionising, the probability of treatment increases
by approximately 20–30%, causing an increase in blood flow,
oxygen, drug delivery and sensitivity of tumours [12,13].
Hyperthermia sensitises tumour cells to drugs and nanopar-
ticles containing the iron oxide core because hyperthermia
eliminates drug resistance and heats iron oxide, thereby
intensifying the effect of hyperthermia and increasing drug
release [14,15].
In this study we have used PLGA-coated nanoparticles as
5-FU carriers with and without the iron oxide core to
determine role of the iron oxide core in thermosensitisation of
the cells. In this nanostructure, 5-FU as a thermosensitiser
drug can load in PLGA as a degradable polymer. PLGA-
coated nanoparticles can facilitate the penetration of 5-FU
into cells. We therefore examined DNA damage induced by
PLGA-coated 5-FU-loaded nanoparticles with or without the
iron oxide core in combination with hyperthermia (43 C for
1 h) in the spheroid model of HT-29 colon cancer cells.
Cultured HT-29 cells can grow as a monolayer or as spheroid
cultures [16,17]. Multicellular spheroids provide more infor-
mation on basic tumour biology and respond to different
therapeutic agents [18].
Materials and methods
Cell line
Human colon cancer cell line HT-29 was obtained from the
Pasteur Institute of Iran, Tehran. The cell line was maintained
in RPMI 1640 (Gibco, Grand Island, NY) supplemented with
10% fetal bovine serum (FBS) (PAA, PAA Laboratories Ply
Ltd, Australia), 100 m/mL of penicillin and 100 mg/mL of
streptomycin (Sigma).
Monolayer culture
HT-29 cells were cultured as a monolayer at a density of 104
cells/cm2 in T-25 tissue culture flasks (Orange Scientific,
Braine-l’Alleud, Belgium). The cultures were maintained at
37 C in a humidified atmosphere of 5% CO2 Cells were
harvested by trypsinising cultures with 1 mM EDTA/0.25%
trypsin (w/v) in phosphate buffer saline (PBS).
Spheroid culture
Spheroids were cultured using the liquid overlay technique:
5 105 HT-29 cells were seeded into 100-mm culture Petri
dishes coated with a thin layer of 1% agar (MERC) with
10 mL of RPMI supplemented with 10% FBS. The plates
were incubated at 37 C in a humidified atmosphere and 5%
CO2. Half of the culture medium was replaced with fresh
culture medium twice per week.
Synthesis of nanoparticles
Synthesis and characterisation of 5-FU- loaded PLGA-coated
nanoparticles with/without iron oxide were based on the
method of Dr Khoee et al. [19]. These biodegradable 5-FU-
loaded nanoparticles with an iron oxide core are synthesised
through modified multiple emulsions–solvent evaporation
methods oil in water, oil in water (o/w/o/w) [19]. For
preparation of nanoparticles, the first oil-based magnetite
nanoparticles were dispersed in dichloromethane (DCM) to
prepare a primary organic phase (O1) Then, the inner aqueous
solution was prepared by dissolving 5-FU and Tween 60 in
double distilled water (W1). The magnetic dispersion (O1)
was emulsified in the inner aqueous solution (W1) by
ultrasonication to obtain an O1/W1 emulsion (dispersion of
magnetite). This primary emulsion was emulsified in an
organic solution (O2) of the polymer (PLGA and Span 60 in
DCM) by ultrasonication to obtain an O1/W1/O2 double
emulsion. Next, this double emulsion was immediately poured
into W2 aqueous solution, which was made of Tween 60
dissolved in distilled water and glycerine, and the mixture was
ultrasonicated again. The resulting multiple emulsion (O1/W1/
O2/W2) was diluted in aqueous solution under mechanical
stirring, and the DCM was removed by solvent evaporation.
Finally, the nanoparticles obtained were dried by freeze-
drying and stored at 4 C. Additionally, PLGA nanoparticles
without drug were prepared in the same way, except that the
inner aqueous solution was prepared with the same amount of
distilled water and Tween 60, but without 5-FU. 5-FU-loaded
nanoparticles without iron oxide core were synthesised
through double emulsions (w/o/w) [20]. Drug-free nanopar-
ticles without iron oxide core were synthesised through
emulsion inversion (o/w) [21].
Characterisation of nanoparticles
Particle size determination
The mean diameter and size distribution of the aqueous
dispersion of nanoparticles were measured by Dynamic Light
Scatterer (DLS) (Brookhaven Instruments, Holtsville, NY,
USA). The sample was diluted to an appropriate concentra-
tion with deionised water, which was filtered previously with
a 0.22mm Millipore filter, to avoid any contamination, and
then sonicated for 10 min and finally the size distribution of
nanoparticles was measured by DLS.
Zeta potential
Zeta potential is an indicator of surface charge, which
determines particle stability in dispersion. Zeta potential of
nanoparticles was determined by a zeta potential analyser.
The nanoparticle was suspended in distilled water and
sonicated for 10 min.
Morphology of nanoparticles
The morphological investigation of nanoparticles was per-
formed using a Zeiss LEO906 (Jena, Germany) transmission
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electron microscope (TEM). The nanoparticle was suspended
in distilled water and sonicated for 10 min. A drop of
nanoparticle suspension was placed on a carbon-coated grid.
The grid was perfectly dried and observed under the TEM at
100 KeV.
Determination of drug content and encapsulation efficiency
To evaluate the drug concentration in a nanoparticle, a UV
absorption measurement was performed. The 5-FU concen-
tration was calculated by application of Beer’s law. First, the
nanoparticles were weighed and re-dissolved in acetone
(spectroscopy grade). Next, the insoluble magnetite particles
were removed from the solution by magnetic separation.
Finally, the 5-FU concentration in the acetone solution was
determined by UV absorption at a wavelength of 201 nm
(characteristic absorption band of 5-FU) with respect to a
previously established calibration curve, and the amount of
encapsulated drug in the nanoparticle was calculated. Drug
content and encapsulation efficiency were obtained using
Equations 1 and 2, respectively:
Drug loading content ð%Þ¼
weight of drug in
nanoparticles
 
weight of nanoparticles
100
ð1Þ
Encapsulation efficiency ð%Þ¼
weight of drug in
nanoparticles
 
weight of feeding
100
ð2Þ
In vitro drug release
The in vitro 5-FU release from PLGA nanoparticles was
performed in PBS medium using the dialysis method. The
dialysis bag (molecular weight cut-off 12,400 Da) was soaked
in preheated at 100 degree of centigrade double-distilled
water before use. A weighed amount of freeze-dried PLGA
nanoparticle samples was suspended in PBS and then
transferred into a dialysis bag. Both ends of the bag were
fixed with clamps. The bag was placed into 100 mL of
preheated at 37 degree of centigrade PBS as a release
medium. The release study was performed in an incubator
shaker at 37 C. At selected time intervals, the solution
outside the dialysis bag was removed (n¼ 3) for UV visible
analysis and replaced with fresh buffer solution. At fixed time
intervals (e.g. 4 days) the medium in the vessel was
completely removed and replaced with fresh release
medium. The 5-FU concentration was calculated based on
the absorbance intensity of 5-FU at 266 nm. In the assessment
of drug release behaviour, the cumulative amount of released
drug was calculated and the percentages of released drug
from PLGA nanoparticles were plotted against time. All
experiments were carried out in triplicate.
Cellular uptake of nanoparticles
After preparing spheroids with mean diameter 100mm, they
were treated with nanoparticles for 71 h, were washed by
phosphate buffer, fixed with 2.5% glutaraldehyde for 1:30 h at
4 C, and washed three times in phosphate buffer 0.1%. After
that, the cells were stained in 1% osmium tetroxide for 1 hour,
washed with phosphate buffer 3 times, then dehydration was
carried out with varying degrees of acetone (50%, 70%, 80%,
90%, and 100%). Then samples were moulded in resin and a
polymerisation procedure was carried out at 60 C for 48 h.
Sections 30–50 nm were then prepared under stereomicro-
scope and placed on a carbon-coated grid. Finally, after
staining with lead citrate and ammonium acetate, images
confirming the entry of nanoparticles into the cell were
observed using a Zeiss LEO906 TEM.
Hyperthermia and 5-FU (-free or -loaded PLGA-coated
nanoparticles with/without iron oxide core) treatment
of spheroid culture
Cells were cultured for multicellular spheroid formation. On
day 10, spheroids with mean diameter of 100 mm were treated
with 1, 5 or 10 mM of 5-FU (Sigma) [22] or the same
concentration of 5-FU released from 5-FU-loaded PLGA-
coated nanoparticles with or without the iron oxide core for
71 h. PLGA nanoparticles were used as a control for the drug-
loaded nanoparticles treatment. Before heat treatment, the
medium was replaced with fresh RPMI 1640 culture medium.
Hyperthermia was applied at 43 C for 60 min in a precision
water bath (Memmert, Schwabach, Germany) with ± 0.1 C
accuracy. Control cells were exposed to 37 C. After heat
treatment, the spheroid cells were treated with 300mL of
1 mM EDTA/0.25% trypsin (w/v) in PBS for 5 min at 37 C.
The single cells were counted and tested for viability using a
trypan blue dye exclusion assay. To evaluate the effect of
treatments performed, single cell gel electrophoresis (alkaline
comet assay) was used.
Trypan blue exclusion assay
A suspension of treated and control single cells from the
spheroid culture were mixed with trypan blue at a 9:1 ratio.
The resulting mixture was examined within 3–5 min under a
light microscope and blue-coloured cells were considered
dead. The ratio of unstained cells to total number of cells was
reported as the viability percentage for each cell category.
Cell characteristics
The HT-29 colon cancer cell line grows as a monolayer on
plastic culture flasks with a population doubling time of
approximately 25 ± 0.39 h. The HT-29 cells are also able to
form spheroids in liquid overlay cultures with a volume
doubling time of approximately 71 ± 3.8 h, which was applied
as drug treatment time consequently.
Alkaline comet assay
DNA fragmentation was assessed using single cell gel
electrophoresis (Comet) assay, previously optimised by our
group [23]. Ordinary microscope slides were coated with 1%
normal melting point agarose. Approximately 10,000 cells
were suspended in 100 mL of 0.5% low melting point agarose.
The cell suspension was rapidly pipetted onto the first agarose
layer. The slides were allowed to solidify, then immersed in
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freshly prepared lysis buffer (2.5 M NaCl, 100 mM EDTA,
10 mM Tris-base with 1% Triton X-100, pH¼ 10) and
incubated for 1 h. From that point on, all the steps were
performed at 4 C. The slides were removed from the lysis
buffer and placed in a horizontal gel electrophoresis tank
(CSLCOM20, Cleaver Scientific, Rugby, UK) which was
filled with fresh cold denaturation buffer (300 mM NaOH,
1 mM EDTA, pH¼ 13). The slides were left in the solution
for 30 min. Electrophoresis was conducted in the same
denaturation buffer for 30 min using 1 V/cm voltage and a
current of 300 mA. Following electrophoresis, the slides were
washed in Tris buffer (0.4 M Tris HCl, pH¼ 7.5) to neutralise
the excess alkali. Finally, the slides were stained with
ethidium bromide (20 mg/mL).The individual cells or comets
were viewed and photographed using a fluorescent micro-
scope (Zeiss, Axioskop2 plus). The photographs were
analysed by Comet Score software. DNA damage was
quantified as an increase in tail moment, the product of the
amount of DNA (fluorescence) in the tail, and the distance
between the means of the head and tail fluorescence
distributions.
Statistical analysis
The results are expressed as mean values ± SEM (Standard
Error Mean), with ‘n’ denoting the number of experiments.
For statistical analysis, one-way ANOVA followed by
Turkey’s test as the post-hoc analysis were performed using
SPSS version 16. The value of p50.05 was considered to be
statistically significant.
Results
Characterisation of nanoparticles
Particle size and zeta potential determination
The zeta potential and particle size was strongly influenced
by the emulsifier used in the fabrication process of the
nanoparticles. The particle size, polydispersity index and zeta
potential of the four types of nanoparticles were measured by
DLS and are shown in Table 1. The nanoparticles formulated
in this study were found to be in the size range of 30–100 nm
and stable in dispersion state, possessing high absolute values
of zeta potential and having negative surface charges.
Morphological studies
TEM measurement was carried out in order to characterise
the morphology of the nanoparticles. Figure 1(A) shows the
photographs of 5-FU-loaded nanoparticles with iron oxide
core and Figure 1(B) shows the photographs free-drug
nanoparticles without iron oxide core. It can be seen that
most of the nanoparticles had a regular spherical shape, and
at optimum conditions the particle size was below 100 nm.
We verified that the nanoparticles had a uniform shape and
size and were well enough dispersed.
Drug content and encapsulation efficiency of
nanoparticles
The drug content and encapsulation efficiency of the
nanoparticles with iron oxide core were 11.5% and 71.8%
and for the nanoparticles without iron oxide core were 10.1%
and 63.1% respectively.
In vitro release profile of 5-FU
Figure 2 shows the cumulative in vitro release profile of 5-FU
from the nanoparticle with/without iron oxide core. It shows
that the nanoparticle with iron oxide core was released to the
extent of 16.5%, but the nanoparticle without iron oxide core
was released to the extent of 14.3% within approximately 71 h
in phosphate buffer at 37 C.
Cellular uptake of nanoparticles
After slide preparation as stated in the previous chapter, the
images confirming the entry of nanoparticles into the cell
were prepared.
Figure 3(A) shows the TEM images of HT-29 spheroids
without any nanoparticles as control samples and Figure 3(B)
shows the uptake of the nanoparticles into HT-29 cells. The
yellow arrows indicate some of the nanoparticles distributed
in the cell.
Effects of 5-FU/5-FU-loaded PLGA-coated
nanoparticles with/without iron oxide core and/or
hyperthermia on viability
Immediately after cell treatment with 1, 5 and 10 mM of 5-FU
or the same concentration of 5-FU released from 5-FU-loaded
PLGA-coated nanoparticles with or without the iron oxide
core for 71 h and hyperthermia, spheroid cells were dispersed
to single cells. They were then counted and viability was
determined using the trypan blue dye exclusion assay.
Figure 4(A–C) show the effect of 5-FU and 5-FU-loaded
nanoparticles with and without iron oxide core and hyper-
thermia on the viability of HT-29 cells from spheroid cultures.
As can be seen, hyperthermia at 43 C in combination with 1,
5 and 10 mM 5-FU or the same concentration of 5-FU released
from 5-FU-loaded PLGA-coated nanoparticles with or with-
out the iron oxide core for 71 h did not have any effect on the
viability of cells in spheroid culture (p40.05).
Table 1. Particle size and Zeta potential of nanoparticles.
Type of nanoparticles
Hydrodynamic
particle size (nm)
Polydispersity
index (PdI) Zeta potential ± SD
5-Fluorouracil-loaded PLGA-coated nanoparticles with iron core 40.6 0.385 22.51 ± 1.62
PLGA-coated nanoparticles with iron core 61.4 0.221 20.82 ± 1.16
5-Fluorouracil-loaded PLGA-coated nanoparticles without iron core 36.2 0.208 27.12 ± 0.29
PLGA-coated nanoparticles without iron core 83.9 0.253 15.44 ± 1.33
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Effects of 5-FU/5-FU-loaded PLGA-coated
nanoparticles with/without iron oxide core and/or
hyperthermia on induced DNA damage
Viability of HT-29 cells was determined using trypan blue
dye exclusion assay. Next, alkaline comet assay was per-
formed to evaluate DNA damage. The average of tail
moments in each category of cells was used as an indicator
of DNA damage. Figure 5 shows the effect of 1, 5 and 10 mM
5-FU and the same concentration of 5-FU in combination
with hyperthermia (43 C for 1 h). Induction of DNA damage
was not significantly different between control cells and cells
treated with510 mM 5-FU because of the low concentration
of 5-FU. Induction of DNA damage in cells treated with 5-FU
in combination with hyperthermia increased with an increase
in the concentration of 5-FU. The extent of DNA damage
in cells treated with 5-FU in combination with hyperthermia
was significantly higher than that in cells treated with
5-FU alone (P50.05). This was because of the synergistic
effect of the drug and hyperthermia. Notably, hyperthermia
alone did not induce DNA damage in spheroid cultures of
HT-29 cells.
Next, we compared the DNA damage induced by 1, 5 and
10 mM 5-FU and that induced by the same concentrations of
5-FU released from 5-FU-loaded PLGA-coated nanoparticles
with or without the iron oxide core for 71 h (Figure 6). The
extent of DNA damage induced by 5-FU released from PLGA
nanoparticles with or without the iron oxide core was
significantly higher than that by the same concentration of
5-FU (p50.001). Moreover, no significant difference was
observed in the extent of DNA damage induced by the drug
released from nanoparticles with the iron oxide core and that
released from nanoparticles without the iron oxide core
(p40.05). This result indicated that the iron oxide core had
no effect on the induction of DNA damage.
Figure 7 shows the effect of treatment with 1, 5 and 10 mM
5-FU released from 5-FU-loaded PLGA-coated nanoparticles
without the iron oxide core and that released from
5-FU-loaded PLGA-coated nanoparticles without the iron
oxide core in combination with hyperthermia for 71 h.
Induction of DNA damage in HT-29 cells was higher with
the combination treatment and increased with an increase in
the concentration of 5-FU. However, the extent of DNA
damage induced by the combination treatment of
5-FU-loaded nanoparticles without the iron oxide core and
hyperthermia was significantly higher than that induced by
5-FU-loaded nanoparticles without the iron oxide core alone
(P50.001). Moreover, free nanoparticles without the iron
oxide core had no significant effect on the induction of DNA
damage compared with control (p40.05).
Figure 8 shows the effect of treatment with 1, 5 and 10 mM
5-FU released from 5-FU-loaded PLGA-coated nanoparticles
with the iron oxide core and that released from 5-FU-loaded
PLGA nanoparticles with the iron oxide core in combination
with hyperthermia for 71 h. Figure 8 confirms the results in
Figure 7, with the exception that nanoparticles contain the
iron oxide core in Figure 8.
The tail moment of each group
The effects of 5-FU-loaded nanoparticles with the iron oxide
core and 5-FU-loaded nanoparticles without the iron oxide
core in combination with hyperthermia are shown in Figure 9.
Figure 1. Transmission electron micrographs of nanoparticles: (A) 5-FU-loaded PLGA-coated nanoparticles with iron core, (B) PLGA-coated
nanoparticles without iron core.
Figure 2. In vitro release profiles of 5-FU from 5-FU-loaded PLGA-
coated nanoparticles with/without iron core. The plot represents
mean ± SD of triplicate results.
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Induction of DNA damage in the spheroid cultures of HT-29
cells increased with an increase in the concentration of 5-FU
released from both types of nanoparticles in the presence of
hyperthermia. However, the extent of DNA damage induced
by 5-FU-loaded nanoparticles with the iron oxide core in
combination with hyperthermia was significantly higher than
that induced by 5-FU-loaded nanoparticles without the iron
oxide core in combination with hyperthermia (p50.001).
These results highlighted the importance of the iron oxide
core in the induction of DNA damage at high temperature
and indicated that the iron oxide core intensified the effect of
hyperthermia.
Discussion
Colon cancer is a common cancer worldwide. This study used
spheroid cultures of human colon cancer cell line HT-29
because studies have shown that spheroid cultures are more
Figure 4. Effects of different concentrations of 5-FU and hyperthermia on (A) 5-FU-loaded PLGA-coated nanoparticles without iron oxide core,
(B) 5-FU-loaded PLGA-coated nanoparticles with iron core with hyperthermia, and (C) the viability of HT-29 spheroid culture cells. The viability was
measured using trypan blue dye exclusion assay method. Mean ± SEM of three experiments.
Figure 3. The images confirm the entry of nanoparticles into the cell: (A) control image, (B) image with nanoparticles.
494 E Esmaelbeygi et al. Int J Hyperthermia, 2015; 31(5): 489–497
similar to in vivo conditions than other cultures [24]. 5-FU, a
halogenated pyrimidine analogue that replaces thymine in
DNA and changes the core functions of cells, is used for
treating colon cancer [5]. However, the indiscriminate nature
of 5-FU is a major limitation for its use. To overcome this,
new therapies such as those involving nanoparticles are used
to release drugs into tumour cells at a molecular level, thereby
increasing the concentration of these drugs within tumour
cells and in turn the sensitivity of the tumour to the drugs. Use
of hyperthermia during chemotherapy increases the tempera-
ture of tumour cells and intensifies the effects of drugs and
nanoparticles [12].
In the present study no significant differences were
observed in the induction of DNA damage between control
cells and cells treated with 510 mM 5-FU (Figure 5). This
result was consistent with the results of a study by Salti et al.
[25] in which HT-29 cells were treated with genistein and
were examined using the comet assay. A study by Fairbairn
et al. showed that hyperthermia alone did not result in
significant DNA damage [26]. However, significant differ-
ences were observed in the induction of DNA damage by
5-FU monotherapy and 5-FU and hyperthermia combination
therapy in the present study, suggesting a synergistic effect of
the drug and hyperthermia. This result was consistent with
that reported by Kido et al. [27] who showed that the
percentage of V-79 cells in the S-phase increased after
treatment with 5-FU. Because cells in the S-phase are
sensitive to heat, significant genotoxic damage was observed
after the application of hyperthermia.
Nanoparticles differ in size, drug loading capacity, drug
stability, drug release, targeting ability and capsule construc-
tion material and methods, which influence the effectiveness
of treatment. Compared to more recent studies involving
PLGA-based nanoparticles [19,28], we used structurally
desirable nanoparticles that could enter the cells of the
digestive system for treating colon cancer.
To evaluate the genotoxic effects of the nanoparticles, we
determined whether these nanoparticles could enter cells by
using TEM imaging (Figure 3). Black grains, indicated by
arrows, represent nanoparticles present in the spheroid
cultures of HT-29 cells. This method was also used by in
Cherukuri et al. [15].
Because 5-FU is hydrophilic, it cannot easily cross the cell
membrane, which is composed of phospholipids. However,
loading of this drug into polymeric nanoparticles facilitates its
entry into cells through phagocytosis. The subsequent release
of the drug into the cells increases its concentration within the
cells, thereby increasing DNA damage. The extent of DNA
damage induced by 5-FU released by 5-FU-loaded nanopar-
ticles with or without the iron oxide core was significantly
higher than that by the same concentration of 5-FU alone
(Figure 5). Therefore, the resultant DNA damage can be
attributed to the ability of nanoparticles to release a large
amount of the drug into tumour cells. The present study is
consistent with that reported by to Mohammadi et al. [29] and
Nair et al. [28] by comet assay and colony assay, respectively.
Free PLGA-coated nanoparticles with or without the iron
oxide core had no significant effect on the induction of DNA
damage (Figure 6). This is because PLGA is a biocompatible
polymer and its use is approved by the US Food and Drug
Administration [30]. In addition, no significant difference was
observed in the tail moment of either type of nanoparticles
(with or without the iron oxide core), indicating that the iron
oxide core did not induce DNA damage.
As stated previously, hyperthermia plays an important role
in increasing the sensitivity of cells and level of DNA damage
(Figures 7 and 8). The extent of DNA damage increased with
an increase in the amount of drug released from the
nanoparticles. Moreover, the extent of DNA damage induced
by 5-FU-loaded nanoparticles in combination with hyperther-
mia was significantly higher than that induced by
5-FU-loaded nanoparticles alone, indicating a synergistic
effect of the nanoparticles and hyperthermia. Khoei et al. [31]
investigated the effect of quercetin-loaded PEG-
polyester-PEG nanoparticles in combination with hyperther-
mia in DU-145 cells and provided confirmatory evidence.
Results of the effect of nanoparticles with and without the
iron oxide core in combination with hyperthermia are shown
in Figure 9. Significant differences were observed in the
two types of nanoparticles at all concentrations of 5-FU.
Figure 5. Effects of different concentrations of 5-FU with and without
hyperthermia on induced DNA damage of HT-29 spheroid culture cells.
Mean ± SEM of three experiments.
Figure 6. Effects of different concentrations of 5-FU or 5-FU-loaded
nanoparticles with and without iron core on induced DNA damage of
HT-29 spheroid culture cells. Mean ± SEM of three experiments.
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The extent of DNA damage induced by 5-FU-loaded
nanoparticles with the iron oxide core in combination with
hyperthermia was higher than that induced by 5-FU-loaded
nanoparticles without the iron oxide core in combination with
hyperthermia, suggesting a synergistic effect of the iron oxide
core and hyperthermia in inducing DNA damage. The iron
oxide alone had no significant effect on the induction of DNA
damage; however, it showed a synergistic effect in combin-
ation with hyperthermia. Jordan et al. [32] compared treat-
ment with magnetic fluid hyperthermia (MFH) and water bath
hyperthermia and showed that the use of ferrofluid during
treatment with water bath hyperthermia or MFH reduced the
shoulder of dose–response curves of cells pre-incubated with
a normal medium at 43 C. Freeman et al. found that l mM
iron that is not cytotoxic to CHO cells at 37 C became
cytotoxic as the temperature increased to 43 C (relative
toxicity factor, 2–4), which is roughly in accordance with our
results (Figure 9) (difference between water bath hyperther-
mia with or without the iron oxide core). This thermosensitis-
ing effect of the iron oxide core at 43 C may be because of
oxidative stress induced by ferric ions, which promotes the
formation of hydroxyl radicals in aqueous solution [33].
Shakeri-Zadeh et al. [34] investigated the effect of
increasing temperature on the effectiveness of nanoparticles
with the iron oxide core. Application of ultrasound increased
the temperature of the nanoparticles by approximately 2.7 C.
This result is consistent with the results of the present study.
Conclusion
Our results demonstrate that hyperthermia is a sensitiser agent
and nanoparticles can readily facilitate the cellular entrance of
5-FU into cancer cells. Our results clearly show that the iron
oxide core of nanoparticles can act as a thermosensitiser and
increase the genotoxicity of hyperthermia.
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